Category Archives: Stem Cell Research

Public release date: 4-Apr-2013 [ | E-mail | Share ] Contact: Les Lang llang@med.unc.edu 919-966-9366 University of North Carolina Health Care CHAPEL HILL, N.C. For the first time, researchers at the University of North Carolina at Chapel Hill have isolated adult stem cells from human intestinal tissue. The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology. It also enables them to explore new tactics to treat inflammatory bowel disease or to ameliorate the side effects of chemotherapy and radiation, which often damage the gut. "Not having these cells to study has been a significant roadblock to research," said senior study author Scott T. Magness, PhD, assistant professor in the departments of medicine, biomedical engineering, and cell and molecular physiology at UNC. "Until now, we have not had the technology to isolate and study these stem cells now we have to tools to start solving many of these problems" The UNC study, published online April 4, 2013, in the journal Stem Cells, represents a leap forward for a field that for many years has had to resort to conducting experiments in cells from mice. While significant progress has been made using … Continue reading →

Apr. 4, 2013 For the first time, researchers at the University of North Carolina at Chapel Hill have isolated adult stem cells from human intestinal tissue. The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology. It also enables them to explore new tactics to treat inflammatory bowel disease or to ameliorate the side effects of chemotherapy and radiation, which often damage the gut. "Not having these cells to study has been a significant roadblock to research," said senior study author Scott T. Magness, PhD, assistant professor in the departments of medicine, biomedical engineering, and cell biology and physiology at UNC. "Until now, we have not had the technology to isolate and study these stem cells -- now we have to tools to start solving many of these problems" The UNC study, published online April 4, 2013, in the journal Stem Cells, represents a leap forward for a field that for many years has had to resort to conducting experiments in cells from mice. While significant progress has been made using mouse models, differences in stem cell biology between mice and humans have kept researchers from investigating new therapeutics for human … Continue reading →

Public release date: 3-Apr-2013 [ | E-mail | Share ] Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation NEW YORK, NY (April 3, 2013) A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists led by David Kahler, PhD, NYSCF Director of Laboratory Automation, have developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired from both healthy and diseased donors. Reported in PLOS ONE, this cell-sorting method consistently selects the highest quality, standardized iPS cells, representing a major step forward for drug discovery and the development of cell therapies. Employing a breakthrough method developed by 2012 Nobel laureate Shinya Yamanaka, MD, PhD, adult cells are "reprogrammed" or reverted to an embryonic-like state, commonly through viral infection. Reprogramming is a dynamic process, resulting in a mixture of fully reprogrammed iPS cells, partially reprogrammed cells, and residual adult cells. Previous protocols to select promising fully reprogrammed cells rely primarily on judging stem cell colonies by eye through a microscope. Cell colonies selected by qualitative measures could include partially reprogrammed cells, a major concern for clinical applications of cell therapies because these cells could become any other cell type in a patient … Continue reading →

Apr. 3, 2013 A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists led by David Kahler, PhD, NYSCF Director of Laboratory Automation, have developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired from both healthy and diseased donors. Reported in PLOS ONE, this cell-sorting method consistently selects the highest quality, standardized iPS cells, representing a major step forward for drug discovery and the development of cell therapies. Employing a breakthrough method developed by 2012 Nobel laureate Shinya Yamanaka, MD, PhD, adult cells are "reprogrammed" or reverted to an embryonic-like state, commonly through viral infection. Reprogramming is a dynamic process, resulting in a mixture of fully reprogrammed iPS cells, partially reprogrammed cells, and residual adult cells. Previous protocols to select promising fully reprogrammed cells rely primarily on judging stem cell colonies by eye through a microscope. Cell colonies selected by qualitative measures could include partially reprogrammed cells, a major concern for clinical applications of cell therapies because these cells could become any other cell type in a patient following transplantation. Additionally for drug efficacy assays and toxicity investigations on iPS cells, heterogeneous cell populations can mar the response of representative iPS … Continue reading →

Gina Lollobrigida sells for cells http://www.euronews.com/ The Italian film legend Gina Lollobrigida is selling off her jewellery to raise money for stem cell research. The octogenarian said ... By: Euronews … Continue reading →

Freedom in the 50 States 2013 - A Race Among the States See what state comes #1 at http://freedominthe50states.org ! The Freedom in the 50 States 2013 index from the Mercatus Center at George Mason University meas... By: MercatusCenter … Continue reading →

Teen Advances Science Under Her Bed (VOA On Assignment Mar. 29) VOA correspondent Suzanne Presto sits down with On Assignment's Alex Villarreal to talk about this year's finalists in the Intel Science Talent Search. Suzan... By: VOAvideo … Continue reading →

Apr. 2, 2013 A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF -- Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem (iPS) cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement. As reported in their Stem Cell Research study, these cell aggregates enable scientists to both model and to study diseases such as Alzheimer's and Parkinson's disease. The NYSCF Alzheimer's disease research team aims to better understand and to find treatments to this disease through stem cell research. For such disorders in which neurons misfire or degenerate, the NYSCF team creates "disease in a dish" models by reprogramming patients' skin and or blood samples into induced pluripotent stem (iPS) cells that can become neurons and the other brain cells affected in the diseases. The cells in our body form three-dimensional networks, essential to tissue function and overall health; however, previous techniques to form complex brain tissue resulted in structures that, while similar in form to naturally … Continue reading →

Mr. Don Karn, V.P. North American Markets for Stemtech International, Inc. heads to Grand Junction, Colorado Thursday, April 4 to share the background, research and products now available through Stemtech, The Stem Cell Nutrition Company. Grand Junction, CO (PRWEB) April 02, 2013 In the 1970s a school teacher began experimenting with a natural growing freshwater plant known as Aphanizomenon flos-aquae (AFA). Those who tried the AFA reported remarkable benefits and sales of the botanical soared through the 1980s. However, the secret to the plants wide range of benefits had yet to be revealed. Christian Drapeau arrived on the AFA scene in the 1990s. As a botanical researcher and neurophysiologist, Christian was asked to research the science behind the benefits of AFA. Inspired by new developments in adult stem cell research, Christian was struck with a novel idea - what if AFA was somehow supporting the body in naturally releasing more stem cells? It wasnt until a decade and 150 experiments later that Drapeau and his team experienced a breakthrough, finally isolating the unique components responsible for AFAs benefits. Now, Christian developed the proprietary blend of AFA concentrates in the form of a supplement, offering consumers a practical method of receiving … Continue reading →

Public release date: 2-Apr-2013 [ | E-mail | Share ] Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation NEW YORK, NY (March 25, 2013) A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem (iPS) cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement. As reported in their Stem Cell Research study, these cell aggregates enable scientists to both model and to study diseases such as Alzheimer's and Parkinson's disease. The NYSCF Alzheimer's disease research team aims to better understand and to find treatments to this disease through stem cell research. For such disorders in which neurons misfire or degenerate, the NYSCF team creates "disease in a dish" models by reprogramming patients' skin and or blood samples into induced pluripotent stem (iPS) cells that can become neurons and the other brain cells affected in the diseases. The cells in our body form three-dimensional networks, essential to tissue … Continue reading →